Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified
ICD-10 F18.959 is a billable code used to indicate a diagnosis of inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified.
F18.959 refers to a condition characterized by the use of inhalants, which are substances that produce chemical vapors that can be inhaled to induce psychoactive effects. This code is used when the inhalant use is unspecified and is associated with an inhalant-induced psychotic disorder, which can manifest as hallucinations, delusions, or other significant changes in thought processes. Inhalants include a variety of substances such as solvents, aerosols, and gases, commonly found in household products. The psychotic disorder resulting from inhalant use can lead to severe impairment in social and occupational functioning. Treatment typically involves a combination of detoxification, counseling, and support groups, focusing on both the substance use disorder and the mental health aspects of inhalant-induced psychosis. Clinicians must carefully assess the patient's history and symptoms to provide appropriate care and ensure accurate coding.
Detailed psychiatric evaluation notes, including history of substance use and mental health symptoms.
Patients presenting with acute psychosis and a history of inhalant use.
Differentiating between primary psychotic disorders and those induced by inhalants.
Comprehensive substance use assessments and treatment plans.
Patients in withdrawal from inhalants or seeking rehabilitation.
Coordination of care with mental health services for dual diagnosis.
Used when assessing a patient for inhalant use and associated psychosis.
Comprehensive assessment notes detailing substance use history and mental health evaluation.
Psychiatric and addiction specialists should collaborate on assessments.
Key symptoms include hallucinations, delusions, and significant changes in behavior or thought processes that occur during or shortly after inhalant use.
